Markets:

Overview

News

Currencies

International

Treasuries

CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

4.150 +0.180 (+4.53%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CytomX Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday ↗

September 07, 2022

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.

Via Benzinga

Recap: CytomX Therapeutics Q2 Earnings ↗

August 04, 2022

CytomX Therapeutics (NASDAQ:CTMX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Via Benzinga

CytomX Therapeutics Cuts Workforce, Extend Cash Runway Into 2025 ↗

July 14, 2022

Via Benzinga

Analyst Ratings for CytomX Therapeutics ↗

July 07, 2022

Analysts have provided the following ratings for CytomX Therapeutics (NASDAQ:CTMX) within the last quarter:

Via Benzinga

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session ↗

September 06, 2022

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

September 06, 2022

Good morning, trader! It's time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Via InvestorPlace

CytomX's Breast Cancer Candidate Meets Primary Goal Of Objective Response Rate ↗

July 07, 2022

Via Benzinga

CytomX Therapeutics: Q1 Earnings Insights ↗

May 05, 2022

CytomX Therapeutics (NASDAQ:CTMX) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Via Benzinga

Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket ↗

September 06, 2022

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.

Via Benzinga

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures ↗

July 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Nasdaq Surges 250 Points; Crude Oil Rises Sharply ↗

July 07, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping 250 points following the release of data on initial jobless claims.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022 ↗

July 11, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 07, 2022

Via Benzinga

This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday ↗

July 08, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 07, 2022

Thursday's session saw 49 companies set new 52-week lows.

Via Benzinga

Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue ↗

July 07, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones jumping more than 200 points following the release of data on initial jobless claims.

Via Benzinga

What To Know About Mizuho's Downgrade of CytomX Therapeutics ↗

July 07, 2022

Mizuho downgraded its rating of CytomX Therapeutics (NASDAQ:CTMX) to Neutral with a price target of $4.00, changing its price target from $16.00 to $4.00. Shares of CytomX Therapeutics are trading down...

Via Benzinga

This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session ↗

July 07, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022 ↗

July 07, 2022

Upgrades

Via Benzinga

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill ↗

July 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 07, 2022

Via Benzinga

This Analyst Cuts Price Target On Microsoft; Here's The Biggest Price Target Changes For Thursday ↗

July 07, 2022

Truist Securities cut Criteo S.A. (NASDAQ: CRTO) price target from $40 to $35. Criteo shares fell 3.5% to close at $22.92 on Wednesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

July 07, 2022

Good morning, trader! We're taking a look at the biggest pre-market stock movers for Thursday that investors need to know about!

Via InvestorPlace

Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday's Pre-Market Session ↗

July 07, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special...

Via Benzinga

U.S. Stock Futures Edge Higher After Fed Minutes ↗

July 07, 2022

Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade on Thursday following the release of Wednesday’s Fed meeting minutes, suggesting inflation remains the central bank's...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 06, 2022

Gainers

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022 ↗

June 24, 2022

Upgrades

Via Benzinga

CytomX Therapeutics Initiates Dosing in Early-Stage Study Of Solid Tumor Settings ↗

May 26, 2022

CytomX Therapeutics, Inc. (NASDAQ: CTMX) initiated enrolment by dosing first patient in a Phase 1 dose-escalation study of CX-904 for patients with advanced solid tumors.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 28, 2022

On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

All News about CytomX Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today